COMMUNIQUÉS West-GlobeNewswire

U.S. FDA accepts New Drug Application for review and grants Priority Review for darolutamide
29/04/2019
Orion Corporation Press release 29 April 2019 at 3.00 p.m. EEST U.S. FDA accepts New Drug Application for review and grants Priority Review for darolutamide Orion Corporation and Bayer today announced that the U.S. Food [...]
EDAP TMS SA : EDAP to Showcase Suite of Therapeutic Ultrasound Products During the American Urology Association Annual Meeting
29/04/2019
EDAP to Provide Live Demonstrations and Host Q&A with Interested Parties at Booth #2211 LYON, France, April 29, 2019 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it [...]
MediPharm Labs Appoints Former Johnson & Johnson Group Product Director as Chief Strategy Officer
29/04/2019
New Pharma Executive Position Created to Advance Corporate Strategy, Global Growth and Strategic Partnerships TORONTO, April 29, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“ [...]
Hendrick Health System selects Allscripts to provide single patient record, billing and database solution
29/04/2019
Health system signs strategic agreement to deploy suite of solutions including Allscripts Sunrise™ Ambulatory EHR, Sunrise™ Financial Manager, Sunrise™ Health Information Manager, FollowMyHealth® and Allscripts Patient [...]
Foamix to Present Late Breaking Data at the 77th Annual Meeting of the Society for Investigative Dermatology
29/04/2019
REHOVOT, Israel and BRIDGEWATER, N.J., April 29, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a clinical stage specialty pharmaceutical company focused on developing [...]
Teneobio Announces US FDA Approval of the Investigational New Drug Application for TNB-383B and the Initiation of Phase I Clinical Studies in Multiple Myeloma Patients
29/04/2019
NEWARK, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- Teneobio, Inc. and its affiliate TeneoOne, Inc. announced today that their investigational new drug application (IND) for TNB-383B, a bispecific T-cell engaging [...]
Krystal Biotech Announces Five Presentations of Clinical and Preclinical Data at the Society for Investigative Dermatology Annual Meeting
29/04/2019
PITTSBURGH, April 29, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company developing medicines to treat rare skin diseases announces presentations of clinical data for [...]
Avadel Pharmaceuticals Announces Appointment of Jordan Dubow, M.D., as Chief Medical Officer
29/04/2019
DUBLIN, Ireland, April 29, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218 for sleep disorders, today announced that it has appointed Jordan Dubow, M.D., as [...]
Evolus to Participate in Two Upcoming Investor Conferences
29/04/2019
IRVINE, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ:EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced today that members of [...]
PetMed Express D/B/A 1-800-PetMeds to Announce Its Fiscal Year End Financial Results on May 6, 2019
29/04/2019
DELRAY BEACH, Fla., April 29, 2019 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) will announce its financial results for the fiscal year ended March 31, 2019 on Monday, May 6, 2019 at 8:00 A.M. Eastern Time, [...]
Soleno Therapeutics Announces Appointment of Industry Veteran Gwen A. Melincoff to Board of Directors
29/04/2019
REDWOOD CITY, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]
Progressive Care, Inc CEO Recognized by Forbes as a Unique Leader
29/04/2019
MIAMI, April 29, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that it has garnered media coverage in Forbes in an article [...]
Scott Shuda Appointed to IRIDEX Board of Directors
29/04/2019
MOUNTAIN VIEW, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced [...]
Extendicare Announces Timing of 2019 First Quarter Results and Conference Call
29/04/2019
MARKHAM, Ontario, April 29, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the first quarter of 2019, after [...]
LogicBio Therapeutics Receives FDA Orphan Drug Designation for LB-001 for the Treatment of Methylmalonic Acidemia
29/04/2019
CAMBRIDGE, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients, today [...]
Medovex Corporation Announces Recent Management Appointments
29/04/2019
Highly Experienced Team Responsible for Building a Previous $250M Plus Revenue Health Care Enterprise Reunited Under CEO Bill Horne ALPHARETTA, Ga., April 29, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX [...]
ChemioCare Announces Appointment of Roy F. Waldron to Its Board of Directors
29/04/2019
NEW YORK, April 29, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a platform company focused on proprietary transdermal delivery, announced today the appointment of Roy F. Waldron to its [...]
Aleafia Health Reports 2018 Fiscal Year-end Results, Provides Corporate Update
29/04/2019
Aleafia & Emblem Y/Y Pro-forma Revenue Increases 327% to $11.5M Buildout of Three Production Facilities Nearing Completion Anticipated Annual Cannabis Cultivation & Extraction Capacity to Reach 138,000 kg, 50, [...]
Immunomedics and Everest Medicines Announce Exclusive License Agreement for Sacituzumab Govitecan in East and Southeast Asia Excluding Japan
29/04/2019
The Largest Single-Asset License Agreement for Greater China To Date Provides Everest Medicines the Right to Develop and Commercialize Sacituzumab Govitecan for All Cancer Indications in Greater China, South Korea, and [...]

Pages